Cargando…
Canine autoimmune hemolytic anemia: management challenges
Immune-mediated hemolytic anemia is one of the most common manifestations of canine immune-mediated disease, yet treatment regimens remain nonstandardized and, in some cases, controversial. The main reason for this, as for most diseases in veterinary medicine, is the lack of large-scale placebo-cont...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055891/ https://www.ncbi.nlm.nih.gov/pubmed/30050843 http://dx.doi.org/10.2147/VMRR.S81869 |
_version_ | 1783341271113269248 |
---|---|
author | Swann, James W Skelly, Barbara J |
author_facet | Swann, James W Skelly, Barbara J |
author_sort | Swann, James W |
collection | PubMed |
description | Immune-mediated hemolytic anemia is one of the most common manifestations of canine immune-mediated disease, yet treatment regimens remain nonstandardized and, in some cases, controversial. The main reason for this, as for most diseases in veterinary medicine, is the lack of large-scale placebo-controlled trials so that the efficacy of one treatment over another can be established. Most of the evidence used for treatment comes from retrospective studies and from personal preference and experience, and because of this, treatment regimens tend to vary among institutions and individual clinicians. Management of immune-mediated hemolytic anemia includes immunosuppression, thromboprophylaxis, and supportive care measures to help prevent and treat concurrent conditions. |
format | Online Article Text |
id | pubmed-6055891 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-60558912018-07-26 Canine autoimmune hemolytic anemia: management challenges Swann, James W Skelly, Barbara J Vet Med (Auckl) Review Immune-mediated hemolytic anemia is one of the most common manifestations of canine immune-mediated disease, yet treatment regimens remain nonstandardized and, in some cases, controversial. The main reason for this, as for most diseases in veterinary medicine, is the lack of large-scale placebo-controlled trials so that the efficacy of one treatment over another can be established. Most of the evidence used for treatment comes from retrospective studies and from personal preference and experience, and because of this, treatment regimens tend to vary among institutions and individual clinicians. Management of immune-mediated hemolytic anemia includes immunosuppression, thromboprophylaxis, and supportive care measures to help prevent and treat concurrent conditions. Dove Medical Press 2016-07-26 /pmc/articles/PMC6055891/ /pubmed/30050843 http://dx.doi.org/10.2147/VMRR.S81869 Text en © 2016 Swann and Skelly. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Review Swann, James W Skelly, Barbara J Canine autoimmune hemolytic anemia: management challenges |
title | Canine autoimmune hemolytic anemia: management challenges |
title_full | Canine autoimmune hemolytic anemia: management challenges |
title_fullStr | Canine autoimmune hemolytic anemia: management challenges |
title_full_unstemmed | Canine autoimmune hemolytic anemia: management challenges |
title_short | Canine autoimmune hemolytic anemia: management challenges |
title_sort | canine autoimmune hemolytic anemia: management challenges |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6055891/ https://www.ncbi.nlm.nih.gov/pubmed/30050843 http://dx.doi.org/10.2147/VMRR.S81869 |
work_keys_str_mv | AT swannjamesw canineautoimmunehemolyticanemiamanagementchallenges AT skellybarbaraj canineautoimmunehemolyticanemiamanagementchallenges |